Search Results - "van Assche, D"

Refine Results
  1. 1

    Gradient acoustic focusing of sub-micron particles for separation of bacteria from blood lysate by Van Assche, David, Reithuber, Elisabeth, Qiu, Wei, Laurell, Thomas, Henriques-Normark, Birgitta, Mellroth, Peter, Ohlsson, Pelle, Augustsson, Per

    Published in Scientific reports (28-02-2020)
    “…Handling of submicron-sized objects is important in many biochemical and biomedical applications, but few methods today can precisely manipulate this range of…”
    Get full text
    Journal Article
  2. 2

    The effectiveness of exercise and physical activity programs on fatigue and sleep in people with arthritis – A systematic review with meta-analysis by Runge, N., Arribas-Romano, A., Labie, C., Mairesse, O., Goossens, Z., Nijs, J., Malfliet, A., Verschueren, S., Van Assche, D., de Vlam, K., De Baets, L.

    Published in Sleep medicine reviews (01-10-2023)
    “…This systematic review aimed to systematically investigate the literature on the effectiveness of exercise and physical activity programs on fatigue and sleep…”
    Get full text
    Journal Article
  3. 3

    Coordination of upper and lower limb segments: deficits on the ipsilesional side after unilateral stroke by DEBAERE, F, VAN ASSCHE, D, KIEKENS, C, VERSCHUEREN, S. M. P, SWINNEN, S. P

    Published in Experimental brain research (01-12-2001)
    “…Coordination of the ipsilateral limbs was studied in unilateral stroke patients and a control group of healthy age-matched controls. Cyclical single-limb…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials by McKenna, S.P., Cook, S.A., Whalley, D., Doward, L.C., Richards, H.L., Griffiths, C.E.M., Van Assche, D.

    Published in British journal of dermatology (1951) (01-08-2003)
    “…Summary  Background Patients with psoriasis have significant impairment in their quality of life (QoL). Several patient‐completed instruments are available to…”
    Get full text
    Journal Article
  6. 6

    A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD) by Whalley, D., Mckenna, S.P., Dewar, A.L., Erdman, R.A., Kohlmann, T., Niero, M., Cook, S.A., Crickx, B., Herdman, M.J., Frech, F., Van Assche, D.

    Published in British journal of dermatology (1951) (01-02-2004)
    “…Summary Background  Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin condition that can have a considerable impact on those…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    The Benefit of Pimecrolimus (Elidel, SDZ ASM 981) on Parents' Quality of Life in the Treatment of Pediatric Atopic Dermatitis by Whalley, Diane, Huels, Jasper, McKenna, Stephen P, van Assche, Daniel

    Published in Pediatrics (Evanston) (01-12-2002)
    “…Two 26-week US clinical trials of identical design were conducted to evaluate the efficacy and safety of pimecrolimus (Elidel, SDZ ASM 981) cream 1% in…”
    Get full text
    Journal Article
  13. 13

    International Development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD) by Stephen P. Mc Kenna, Whalley, Diane, Abigail L. Dewar, Ruud A. M. Erdman, Thomas Kohlmann, Mauro Niero, Eva Baró, Sharon A. Cook, Beatrice Crickx, Feride Frech, Daniel van Assche

    Published in Quality of life research (01-02-2005)
    “…Objective: The international development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD), a quality of life (QoL) instrument specific…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health-related quality of life by McKenna, SP, Whalley, D, de Prost, Y, Staab, D, Huels, J, Paul, CF, van Assche, D

    “…Aim  To report on quality of life (QoL) and health‐related quality of life (HRQL) impacts of pimecrolimus (Elidel®, Novartis A.G., Basel, Switzerland, SDZ ASM…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20